CLRM-10 ENHANCED PATIENT CARE FOR BRAIN METASTASIS PATIENTS UTILIZING A DEDICATED METASTASIS TUMOR BOARD

Abstract BACKGROUND Patients with brain metastases are a heterogeneous population. In contrast to patients primary tumors, these require individualized therapy based on the type and status of systemic cancer, number volume metastases, anticipated efficacy survival. Therapeutic options for metastasis; surgical, radiation precision medicine approaches have increased in recent years as has survival cancers, leading more sophisticated care. To meet this challenge January 2023 we organized dedicated metastasis tumor board. METHODS We reviewed total patients, those newly-diagnosed, presented at board first 10 weeks compared same time interval prior year where similar cases were general also assessed change practice pattern RESULTS 89 2023, including 75 who newly diagnosed. The diagnosed 17% higher than year. board, staffed by experts allowed earlier identification eligible clinical trial additionally our review identified need standardizing advanced imaging techniques high resolution, contrast-dose MRI scans better assessment across hospital sites. CONCLUSION found that multidisciplinary review, new which served identify trial. It led consensus incorporate assessing treatment response. experience is superior inclusion